FIELD: medicine; obstetrics; gynecology.
SUBSTANCE: invention can be used to predict the risk of developing preeclampsia (PE) in pregnant women with type 1 diabetes. At a period of 11 to 13 weeks and 6 days of pregnancy, a combination of the following indicators is assessed: age, the presence of vasculopathy, the level of glycated hemoglobin HbAlc, mean arterial pressure (MAP), Doppler pulsation index of the uterine arteries (PI UA), biochemical markers in blood serum: level sFLT/PlGF, sEng level. Based on the values obtained, the risk of developing PE is calculated as a percentage according to a given formula.
EFFECT: method allows to increase the accuracy of risk assessment of preeclampsia by assessing the totality of specific biochemical markers and anamnestic risk factors for the development of the disease.
1 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING THE RISK OF PRE-ECLAMPSIA IN PREGNANT WOMEN WITH TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2800716C1 |
| METHOD FOR PREDICTING THE RISK OF PREECLAMPSIA IN PREGNANT WOMEN WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2751139C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA IN PREGNANT WOMEN WITH VARIOUS TYPES OF DIABETES MELLITUS | 2021 |
|
RU2767912C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF PRE-ECLAMPSIA IN WOMEN OF DIFFERENT SOMATOTYPES | 2018 |
|
RU2679111C1 |
| METHOD OF PROLONGING PREGNANCY IN EARLY PRE-ECLAMPSIA | 2023 |
|
RU2803574C1 |
| METHOD FOR PREECLAMPSIA DIAGNOSTICS IN PREGNANT WOMEN WITH CHRONIC KIDNEY DISEASE | 2016 |
|
RU2623057C1 |
| METHOD FOR PREDICTING ADVERSE PREGNANCY OUTCOMES IN WOMEN WITH TYPE 1 DIABETES MELLITUS IN THE SECOND HALF OF PREGNANCY | 2020 |
|
RU2759076C1 |
| METHOD FOR PREDICTION OF PREECLAMPSIA IN PREGNANT WOMEN SUFFERING FROM PLACENTAL INSUFFICIENCY | 2013 |
|
RU2545760C2 |
| PREDICTION OF PREECLAMPSIA BASED ON DETERMINING EXTRACELLULAR FETAL DNA IN MATERNAL BLOOD WHEN SCREENING THE FIRST TRIMESTER OF PREGNANCY | 2019 |
|
RU2697845C1 |
| METHOD FOR CHOOSING MANAGEMENT APPROACH TO PREGNANT WOMEN WITH MODERATE PREECLAMPSIA | 2011 |
|
RU2477481C1 |
